On October 23, 2025, A.I.dvisor detected a Cup-and-Handle Pattern (Bullish) for CareTrust REIT (CTRE, $34.93). On October 23, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $37.78. 33 days later, on November 25, 2025, CTRE reached the target price resulting in a for traders who took a long position in the stock.
CTRE saw its Momentum Indicator move above the 0 level on November 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for CTRE just turned positive on November 03, 2025. Looking at past instances where CTRE's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
CTRE moved above its 50-day moving average on October 30, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTRE advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 299 cases where CTRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTRE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CTRE broke above its upper Bollinger Band on November 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.081) is normal, around the industry mean (2.168). P/E Ratio (27.368) is within average values for comparable stocks, (69.757). CTRE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.242). Dividend Yield (0.035) settles around the average of (0.064) among similar stocks. CTRE's P/S Ratio (22.272) is very high in comparison to the industry average of (7.004).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a real estate investment trust
Industry ManagedHealthCare